Cafepharma Today

November 20 2024 - Novo, Viking heat up MASH space with promising data at AASLD24
Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Incyte sinks on setback for drugs acquired in $750M buyout
BioPharma Dive
Tuesday, November 19, 2024 - 7:10pm
tags:
Incyte, Escient Pharma, M&A
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Yahoo/Benzinga
Tuesday, November 19, 2024 - 7:09pm
tags:
Bristol Myers Squibb, ACR, clinical trials, autoimmune disease
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:22am
tags:
prostate cancer, clinical trials, Candel Therapeutics, ProstAtak, JNJ, Akeega, Pfizer, Mevrometostat
Bayer lands regional rights to aficamten in Japan deal with Cytokinetics
First Word Pharma
Tuesday, November 19, 2024 - 11:20am
tags:
Bayer, Japan, Cytokinetics, aficamten, hypertrophic cardiomyopathy
GSK scratches itch for phase 3 win, hitting goal in liver disease trial to open up untapped market
Fierce Biotech
Tuesday, November 19, 2024 - 11:18am
tags:
GSK, linerixibat, liver disease, clinical trials
Merck says Keytruda injection on par with approved IV version in trial
CNBC
Tuesday, November 19, 2024 - 11:17am
tags:
Merck, Keytruda, IVs
Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown
Fierce Biotech
Tuesday, November 19, 2024 - 11:16am
tags:
Eli Lilly, lipoproteins, clinical trials, cholesterol, muvalaplin
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Tip Ranks
Tuesday, November 19, 2024 - 11:13am
tags:
Astellas, Apellis, FDA, geographic atrophy, Izervay, Syfovre
Toragen reports positive results from trial of TGN-S11 for HPV-related cancer
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:10am
tags:
Toragen, TGH-S11, HPV, clinical trials
Nationwide IV fluid shortage changing how hospitals manage patient hydration
NPR
Tuesday, November 19, 2024 - 11:05am
tags:
IVs, Medtech, shortages
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:00am
tags:
JNJ, clinical trials, JNJ-2113, psoriasis
Future of Medicare drug price negotiations under new administration: 5 things to know
Beckers Hospital Review
Tuesday, November 19, 2024 - 10:59am
tags:
Medicare, Inflation Reduction Act, drug pricing, Donald Trump
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Pharma Voice
Tuesday, November 19, 2024 - 10:57am
tags:
AbbVie, R&D, virology
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Mass Device
Monday, November 18, 2024 - 6:44pm
tags:
Abbott Labs, Medtech, Ireland, FreeStyle Libre, diabetes
Sanofi lays out €40M to beef up transplant, diabetes drug production in France
Fierce Pharma
Monday, November 18, 2024 - 6:37pm
tags:
Sanofi, diabetes, type 1 diabetes, France, drug manufacturing
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome
Fierce Pharma
Monday, November 18, 2024 - 6:36pm
tags:
Eisai, obesity, lorcaserin
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
BioPharma Dive
Monday, November 18, 2024 - 6:32pm
tags:
Rengexbio, DMD, gene therapy, FDA, RGX-202
Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Clinical Trials Arena
Monday, November 18, 2024 - 6:30pm
tags:
Alnylam Pharmaceuticals, nucresiran, RNAi, clinical trials
Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks
Fierce Biotech
Monday, November 18, 2024 - 11:32am
tags:
Novartis, radiopharmaceuticals, Ration Therapeutics, biobucks
Intellia’s gene editing therapy shows early potential in rare heart condition
Clinical Trials Arena
Monday, November 18, 2024 - 11:30am
tags:
Intellia, gene editing, NTLA-2001, AHA, ATTR-CM

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Down There in the Nano-Flow
In the Pipeline
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
Drug Channels
CNS Drug Development: Same As It Ever Was
In the Pipeline
From Integration to AI: The Data-Driven Future of Market Access
Drug Channels
On RFK Jr. And What We're In For
In the Pipeline
Natural-Ish Product Motifs
In the Pipeline
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Deuterium In Court
In the Pipeline
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels

Latest Jobs

Area Manager, Specialty Southeast
Fields, Oregon, 97710
CSL Behring
Neuroscience Account Manager - Milwaukee, WI
Milwaukee, Wisconsin, US
Lundbeck
BioPharmaceutical Account Manager - Houston South, TX
Houston, Texas, US
Lundbeck
Associate Director, Strategic Account Management -Pacific
San Francisco, California
AbbVie
Senior Director, US HIV Prevention Launch Hub Lead
Foster City, California
Gilead Sciences, Inc.
Therapy Development Manager Transcatheter Heart Valve
San Diego, California, 92189
Edwards Lifesciences
Neuroscience Account Manager (Psychiatry) - Missoula, MT
Missoula, Montana, 59812
Vanda Pharmaceuticals
Senior Account Manager IV Therapy - Northern CA / Nevada
Honolulu, Hawaii, 96814
Fresenius Kabi USA, LLC
Psychiatry Account Manager - Dayton West, OH
Oakwood, Ohio, 45873
Lundbeck
Neuroscience Account Manager (Psychiatry) - Detroit East, MI
Hamtramck, Michigan, 48212
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information